The saftey and efficacy of intradermal injection of type A butulinum toxin in chemotherapy induced peripheral neuropathy
Phase 3
- Conditions
- Chemotherapy induced neuropathy.
- Registration Number
- IRCT20200425047202N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Chemotherapy induced neuropathy in patients treated with taxans or platinums with grade 2 or more of neuropathy
Exclusion Criteria
Lack of cooperation///////
History of neuropathy before chemotherapy
History of allergy to the butulinum toxin
Local infection of the injection places
Rradiculopathy
History of mental disease
Alcolol or substance abuse
Known renal disease
History of miastenia gravis
Use of aminoglycosides
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method